Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
OraSure Technologies
OSUR
OraSure Technologies
Diagnostics Will Face Funding Cuts Yet Show Signs Of Resilience
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 1 Analyst
Published
29 May 25
Updated
16 Jul 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$5.00
44.4% undervalued
intrinsic discount
16 Jul
US$2.78
Loading
1Y
-34.1%
7D
-7.6%
Author's Valuation
US$5.0
44.4% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$5.0
44.4% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-64m
480m
2014
2017
2020
2023
2025
2026
2028
Revenue US$146.4m
Earnings US$19.2m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
3.12%
Medical Equipment revenue growth rate
0.32%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.62%
Calculation
US$19.17m
Earnings '28
x
24.08x
PE Ratio '28
=
US$461.60m
Market Cap '28
US$461.60m
Market Cap '28
/
75.50m
No. shares '28
=
US$6.11
Share Price '28
US$6.11
Share Price '28
Discounted to 2025 @ 7.17% p.a.
=
US$4.97
Fair Value '25
